Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome

Journal of Experimental Medicine

Volumn 206, Issue 6, 2009, Pages 1291-1301

  Minegishi, Yoshiyuki ^a   Saito, Masako ^a   Nagasawa, Masayuki ^a   Takada, Hidetoshi ^b   Hara, Toshiro ^b   Tsuchiya, Shigeru ^c   Agematsu, Kazunaga ^d   Yamada, Masafumi ^e   Kawamura, Nobuaki ^e   Ariga, Tadashi ^e   Tsuge, Ikuya ^f   Karasuyama, Hajime ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d SHINSHU UNIVERSITY   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CANDIDA ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 8;

ARTICLE; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; HYPER IGE SYNDROME; KERATINOCYTE; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; TH17 CELL;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, FUNGAL; BETA-DEFENSINS; CHEMOKINES; CYTOKINES; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-8; JOB'S SYNDROME; KERATINOCYTES; LUNG DISEASES; RECEPTORS, INTERLEUKIN-1; RESPIRATORY MUCOSA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 67449149963     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20082767     Document Type: Article

References (46)

1. Dong, C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8:337-348. (Pubitemid 351595217)
2. Ivanov, I.I., L. Zhou, and D.R. Littman. 2007. Transcriptional regulation of Th17 cell differentiation. Semin. Immunol. 19:409-417. (Pubitemid 351274050)
3. Chen, Z., A. Laurence, and J.J. O'Shea. 2007. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin. Immunol. 19:400-408.
4. McGeachy, M.J., K.S. Bak-Jensen, Y. Chen, C.M. Tato, W. Blumenschein, T. McClanahan, and D.J. Cua. 2007. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8:1390-1397. (Pubitemid 350138974)
5. Cua, D.J., J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 421:744-748. (Pubitemid 36227625)
6. Korn, T., M. Oukka, and E. Bettelli. 2007. Th17 cells: effector T cells with inflammatory properties. Semin. Immunol. 19:362-371. (Pubitemid 351274046)
7. Aujla, S.J., P.J. Dubin, and J.K. Kolls. 2007. Th17 cells and mucosal host defense. Semin. Immunol. 19:377-382. (Pubitemid 351274047)
8. Ouyang, W., J.K. Kolls, and Y. Zheng. 2008. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 28:454-467.
9. Diveu, C., M.J. McGeachy, and D.J. Cua. 2008. Cytokines that regulate autoimmunity. Curr. Opin. Immunol. 20:663-668.
10. Iwakura, Y., S. Nakae, S. Saijo, and H. Ishigame. 2008. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol. Rev. 226:57-79.
11. Kolls, J.K., and A. Linden. 2004. Interleukin-17 family members and inflammation. Immunity. 21:467-476. (Pubitemid 39370503)
12. Kolls, J.K., P.B. McCray Jr., and Y.R. Chan. 2008. Cytokine-mediated regulation of antimicrobial proteins. Nat. Rev. Immunol. 8:829-835.
13. Kreymborg, K., R. Etzensperger, L. Dumoutier, S. Haak, A. Rebollo, T. Buch, F.L. Heppner, J.C. Renauld, and B. Becher. 2007. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179:8098-8104.
14. Wolk, K., S. Kunz, E. Witte, M. Friedrich, K. Asadullah, and R. Sabat. 2004. IL-22 increases the innate immunity of tissues. Immunity. 21:241-254. (Pubitemid 39094053)
15. Toy, D., D. Kugler, M. Wolfson, T. Vanden Bos, J. Gurgel, J. Derry, J. Tocker, and J. Peschon. 2006. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J. Immunol. 177:36-39. (Pubitemid 43939112)
16. Aujla, S.J., Y.R. Chan, M. Zheng, M. Fei, D.J. Askew, D.A. Pociask, T.A. Reinhart, F. McAllister, J. Edeal, K. Gaus, et al. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14:275-281. (Pubitemid 351347908)
17. Zheng, Y., P.A. Valdez, D.M. Danilenko, Y. Hu, S.M. Sa, Q. Gong, A.R. Abbas, Z. Modrusan, N. Ghilardi, F.J. de Sauvage, and W. Ouyang. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14:282-289. (Pubitemid 351347912)
18. Ishigame, H., S. Kakuta, T. Nagai, M. Kadoki, A. Nambu, Y. Komiyama, N. Fujikado, Y. Tanahashi, A. Akitsu, H. Kotaki, et al. 2009. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity. 30:108-119.
19. Higgins, S.C., A.G. Jarnicki, E.C. Lavelle, and K.H. Mills. 2006. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177:7980-7989. (Pubitemid 44846315)
20. Chung, D.R., D.L. Kasper, R.J. Panzo, T. Chitnis, M.J. Grusby, M.H. Sayegh, and A.O. Tzianabos. 2003. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J. Immunol. 170:1958-1963. (Pubitemid 36197415)
21. Shibata, K., H. Yamada, H. Hara, K. Kishihara, and Y. Yoshikai. 2007. Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178:4466-4472. (Pubitemid 46492398)
22. Huang, W., L. Na, P.L. Fidel, and P. Schwarzenberger. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190:624-631. (Pubitemid 38982105)
23. Milner, J.D., J.M. Brenchley, A. Laurence, A.F. Freeman, B.J. Hill, K.M. Elias, Y. Kanno, C. Spalding, H.Z. Elloumi, M.L. Paulson, et al. 2008. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 452:773-776.
24. Ma, C.S., G.Y. Chew, N. Simpson, A. Priyadarshi, M. Wong, B. Grimbacher, D.A. Fulcher, S.G. Tangye, and M.C. Cook. 2008. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J. Exp. Med. 205:1551-1557. (Pubitemid 351962018)
25. de Beaucoudrey, L., A. Puel, O. Filipe-Santos, A. Cobat, P. Ghandil, M. Chrabieh, J. Feinberg, H. von Bernuth, A. Samarina, L. Janniere, et al. 2008. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J. Exp. Med. 205:1543-1550. (Pubitemid 351962017)
26. Renner, E.D., S. Rylaarsdam, S. Anover-Sombke, A.L. Rack, J. Reichenbach, J.C. Carey, Q. Zhu, A.F. Jansson, J. Barboza, L.F. Schimke, et al. 2008. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J. Allergy Clin. Immunol. 122:181-187. (Pubitemid 351899074)
27. Minegishi, Y., M. Saito, S. Tsuchiya, I. Tsuge, H. Takada, T. Hara, N. Kawamura, T. Ariga, S. Pasic, O. Stojkovic, et al. 2007. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 448:1058-1062. (Pubitemid 47345590)
28. Holland, S.M., F.R. DeLeo, H.Z. Elloumi, A.P. Hsu, G. Uzel, N. Brodsky, A.F. Freeman, A. Demidowich, J. Davis, M.L. Turner, et al. 2007. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357:1608-1619. (Pubitemid 47598403)
29. Grimbacher, B., S.M. Holland, and J.M. Puck. 2005. Hyper-IgE syndromes. Immunol. Rev. 203:244-250. (Pubitemid 40179705)
30. Minegishi, Y., and H. Karasuyama. 2007. Hyperimmunoglobulin E syndrome and tyrosine kinase 2 deficiency. Curr. Opin. Allergy Clin. Immunol. 7:506-509. (Pubitemid 350076445)
31. Minegishi, Y., and H. Karasuyama. 2008. Genetic origins of hyper-IgE syndrome. Curr. Allergy Asthma Rep. 8:386-391.
32. Minegishi, Y., and H. Karasuyama. 2009. Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency. Int. Immunol. 21:105-112.
33. Winkelstein, J.A., M.C. Marino, R.B. Johnston Jr., J. Boyle, J. Curnutte, J.I. Gallin, H.L. Malech, S.M. Holland, H. Ochs, P. Quie, et al. 2000. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 79:155-169. (Pubitemid 30327530)
34. Sumikawa, Y., H. Asada, K. Hoshino, H. Azukizawa, I. Katayama, S. Akira, and S. Itami. 2006. Induction of beta-defensin 3 in keratinocytes stimulated by bacterial lipopeptides through toll-like receptor 2. Microbes Infect. 8:1513-1521. (Pubitemid 44192354)
35. Pivarcsi, A., L. Bodai, B. Rethi, A. Kenderessy-Szabo, A. Koreck, M. Szell, Z. Beer, Z. Bata-Csorgoo, M. Magocsi, E. Rajnavolgyi, et al. 2003. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int. Immunol. 15:721-730. (Pubitemid 36675803)
36. Happel, K.I., P.J. Dubin, M. Zheng, N. Ghilardi, C. Lockhart, L.J. Quinton, A.R. Odden, J.E. Shellito, G.J. Bagby, S. Nelson, and J.K. Kolls. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202:761-769. (Pubitemid 41345965)
37. Tan, W., W. Huang, Q. Zhong, and P. Schwarzenberger. 2006. IL-17 receptor knockout mice have enhanced myelotoxicity and impaired hemopoietic recovery following gamma irradiation. J. Immunol. 176:6186-6193.
38. Yoshimura, A., E. Lien, R.R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock. 1999. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163:1-5. (Pubitemid 29295815)
39. Lien, E., T.J. Sellati, A. Yoshimura, T.H. Flo, G. Rawadi, R.W. Finberg, J.D. Carroll, T. Espevik, R.R. Ingalls, J.D. Radolf, and D.T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:33419-33425. (Pubitemid 129511647)
40. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C.J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274:17406-17409. (Pubitemid 129519082)
41. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 11:443-451. (Pubitemid 29504199)
42. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392-5396. (Pubitemid 30836143)
43. Ku, C.L., H. von Bernuth, C. Picard, S.Y. Zhang, H.H. Chang, K. Yang, M. Chrabieh, A.C. Issekutz, C.K. Cunningham, J. Gallin, et al. 2007. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 204:2407-2422. (Pubitemid 47529326)
44. Hawn, T.R., A. Ozinsky, L.M. Williams, S. Rodrigues, A. Clark, U. Pham, H.R. Hill, H. Ochs, A. Aderem, and W.C. Liles. 2005. Hyper-IgE syndrome is not associated with defects in several candidate toll-like receptor pathway genes. Hum. Immunol. 66:842-847. (Pubitemid 41169775)
45. Renner, E.D., I. Pawlita, F. Hoffmann, V. Hornung, D. Hartl, M. Albert, A. Jansson, S. Endres, G. Hartmann, B.H. Belohradsky, and S. Rothenfusser. 2005. No indication for a defect in toll-like receptor signaling in patients with hyper-IgE syndrome. J. Clin. Immunol. 25:321-328. (Pubitemid 41204256)
46. Yu, H., M. Kortylewski, and D. Pardoll. 2007. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat. Rev. Immunol. 7:41-51. (Pubitemid 46020826)